DIFFERENTIAL EFFECT OF TYPE-I AND TYPE-II DIABETES-MELLITUS ON ANTIPYRINE ELIMINATION

被引：0
|
作者：
ADITHAN, C [1 ]
DANDA, D [1 ]
SHASHINDRAN, CH [1 ]
BAPNA, JS [1 ]
SWAMINATHAN, RP [1 ]
CHANDRASEKAR, S [1 ]
机构：
[1] JAWAHARLAL INST POSTGRAD MED EDUC & RES,DEPT MED,PONDICHERRY 605006,INDIA
来源：
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 1989年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：755 / 758
页数：4
相关论文
共 50 条
  • [21] APPEARANCE OF TYPE-II DIABETES-MELLITUS IN TYPE-I DIABETIC RECIPIENTS OF PANCREAS ALLOGRAFTS
    HUNSICKER, LG
    SMITH, JL
    YUH, WTC
    WRIGHT, FH
    GODDARD, L
    CORRY, RJ
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2852 - 2853
  • [22] SIMILAR RATE OF PROGRESSION IN THE PREDIALYSIS PHASE IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    BIESENBACH, G
    JANKO, O
    ZAZGORNIK, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1097 - 1102
  • [23] LIPOPROTEIN(A) IN PATIENTS WITH TYPE-I AND TYPE-II DIABETES-MELLITUS AND VARIOUS DEGREES OF NEPHROPATHY
    BARTENS, W
    ZIMMERMANN, J
    SCHRAMM, L
    HEIDBREDER, E
    WANNER, C
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 446 - 446
  • [24] ANTIPYRINE DISPOSITION IN TYPE-I AND TYPE-II DIABETICS
    ZYSSET, T
    WIETHOLZ, H
    THERAPIE, 1988, 43 (02): : 158 - 158
  • [25] TYPE-I DIABETES-MELLITUS
    CUDWORTH, AG
    DIABETOLOGIA, 1978, 14 (05) : 281 - 291
  • [26] TYPE-II DIABETES-MELLITUS
    DAVIDSON, MB
    WESTERN JOURNAL OF MEDICINE, 1985, 142 (06): : 834 - 835
  • [27] APOLIPOPROTEINS (AI, AII, B), LP (A), LCAT IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    PRAGER, R
    SCHERNTHANER, G
    KOSTNER, G
    MUHLHAUSER, I
    DIEPLINGER, H
    DIABETOLOGIA, 1980, 19 (03) : 308 - 308
  • [28] INFLUENCE OF TYPE-I AND TYPE-II DIABETES-MELLITUS ON PHENYTOIN STEADY-STATE LEVELS
    ADITHAN, C
    SRINIVAS, B
    INDHIRESAN, J
    SHASHINDRAN, CH
    BAPNA, JS
    THAKUR, LC
    SWAMINATHAN, RP
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1991, 29 (08) : 310 - 313
  • [29] DAY-TO-DAY VARIATION IN GLYCEMIC CONTROL IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    BANTLE, JP
    LAINE, DC
    DIABETES RESEARCH CLINICAL AND EXPERIMENTAL, 1988, 8 (03): : 147 - 149
  • [30] EFFICACY AND SAFETY OF PRAVASTATIN IN THE TREATMENT OF PATIENTS WITH TYPE-I OR TYPE-II DIABETES-MELLITUS AND HYPERCHOLESTEROLEMIA
    RASKIN, P
    GANDA, OP
    SCHWARTZ, S
    WILLARD, D
    ROSENSTOCK, J
    LODEWICK, PA
    CRESSMAN, MD
    PHILLIPSON, B
    WEINER, B
    MCGOVERN, ME
    NORTON, JM
    CUCINOTTA, GG
    BEHOUNEK, BD
    AMERICAN JOURNAL OF MEDICINE, 1995, 99 (04): : 362 - 369
12345